# Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

> **NCT00277394** · PHASE4 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 541 (actual)

## Conditions studied

- Deep Vein Thrombosis

## Interventions

- **DRUG:** innohep®
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT00277394
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-05
- **Final completion:** 2008-07
- **Target enrollment:** 541 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277394, "Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00277394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*